相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation
Mashhood A. Sheikh et al.
BIOLOGICAL PSYCHIATRY (2023)
Risperidone Reduces Matrix Metalloproteinase-9 and Increases Neurotrophin-3 in Schizophrenia Spectrum of Disorder
Raghavi Chenniappan et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2022)
The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study
Johanna Seitz-Holland et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors
Christoph U. Correll et al.
WORLD PSYCHIATRY (2022)
Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia
Zhengyuan Huang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2022)
Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms
Ece Yazla et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2022)
Altered Intestinal Permeability Biomarkers in Schizophrenia: A Possible Link with Subclinical Inflammation
Kuppan Gokulakrishnan et al.
ANNALS OF NEUROSCIENCES (2022)
Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients
Armando L. Morera-Fumero et al.
ACTA NEUROPSYCHIATRICA (2022)
Serum zonulin and claudin-5 levels in patients with schizophrenia
Ayse Usta et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Matrix metalloproteinase-9 increases the risk of cognitive impairment in schizophrenia
Neha Keshri et al.
NORDIC JOURNAL OF PSYCHIATRY (2021)
BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia
Betul Aslan Turkmen et al.
BMC PSYCHIATRY (2021)
Activity of selected metalloproteinases in neurodegenerative diseases of the central nervous system as exemplified by dementia and schizophrenia
Aneta Tylec et al.
PSYCHIATRIA POLSKA (2021)
Salivary microbiome profiling reveals a dysbiotic schizophrenia-associated microbiota
Ying Qing et al.
NPJ SCHIZOPHRENIA (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia A Systematic Review and Meta-analysis
Katsuhiko Hagi et al.
JAMA PSYCHIATRY (2021)
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
Gael B. Morrow et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole
Vjekoslav Peitl et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis
Federica Klaus et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
Elzbieta Kozlowska et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Metabolic syndrome in antipsychotic-naive patients with first-episode psychosis: a systematic review and meta-analysis
Nathalia Garrido-Torres et al.
PSYCHOLOGICAL MEDICINE (2021)
Neurovascular coupling and oxygenation are decreased in hippocampus compared to neocortex because of microvascular differences
K. Shaw et al.
NATURE COMMUNICATIONS (2021)
Brain capillary structures of schizophrenia cases and controls show a correlation with their neuron structures
Rino Saiga et al.
SCIENTIFIC REPORTS (2021)
Psychopathological Symptom Load and Distinguishable Cerebral Blood Flow Velocity Patterns in Patients With Schizophrenia and Healthy Controls: A Functional Transcranial Doppler Study
Stephan T. Egger et al.
FRONTIERS IN PSYCHIATRY (2021)
Relationships Among Retinal Nerve Fiber Layer Thickness, Vascular Endothelial Growth Factor, and Cognitive Impairment in Patients with Schizophrenia
Yanhong Liu et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)
Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
Helen Q. Cai et al.
MOLECULAR PSYCHIATRY (2020)
Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
Shinsuke Hidese et al.
TRANSLATIONAL PSYCHIATRY (2020)
Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
Wataru Omori et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Blazej Misiak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Different serum protein factor levels in first-episode drug-naive patients with schizophrenia characterized by positive and negative symptoms
Nan Dai et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Overdispersed gene expression in schizophrenia
Guangzao Huang et al.
NPJ SCHIZOPHRENIA (2020)
The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia
Gabriela Radu et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia
Noriko Kudo et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
Three-dimensional alteration of neurites in schizophrenia
Ryuta Mizutani et al.
TRANSLATIONAL PSYCHIATRY (2019)
Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients
Kristina Neugebauer et al.
FRONTIERS IN PSYCHIATRY (2019)
Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis
Sarah Elmi et al.
ASIAN JOURNAL OF PSYCHIATRY (2019)
The difference in serum proteomes in schizophrenia and bipolar disorder
Liudmila Smirnova et al.
BMC GENOMICS (2019)
Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?
Jasmina Arabska et al.
NORDIC JOURNAL OF PSYCHIATRY (2019)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Abnormal levels of vascular endothelial biomarkers in schizophrenia
Tanya T. Nguyen et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Immune and metabolic alterations in first episode psychosis (FEP) patients
Luisella Bocchio-Chiavetto et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia
Charilaos Gerasimou et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2018)
Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia
Wenhuan Xiao et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia
Yezhe Lin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis
Donald C. Goff et al.
JAMA PSYCHIATRY (2018)
The blood-brain barrier in psychosis
Thomas A. Pollak et al.
LANCET PSYCHIATRY (2018)
A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury
Eric Peter Thelin et al.
ACTA NEUROCHIRURGICA (2017)
Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T
Jun Hua et al.
SCHIZOPHRENIA BULLETIN (2017)
Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia
R. Balotsev et al.
EUROPEAN PSYCHIATRY (2017)
A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
X-Y Qin et al.
MOLECULAR PSYCHIATRY (2017)
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Costantino Iadecola
NEURON (2017)
Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls
Satyajit Mohite et al.
PLOS ONE (2017)
Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia
Armando L. Morera-Fumero et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia
Song Chen et al.
PSYCHIATRY RESEARCH (2017)
Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications
Fahmy T. Ali et al.
SCHIZOPHRENIA RESEARCH (2017)
Task and resting-state fMRI studies in first-episode schizophrenia: A systematic review
Tumbwene E. Mwansisya et al.
SCHIZOPHRENIA RESEARCH (2017)
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia
G. Kannan et al.
TRANSLATIONAL PSYCHIATRY (2017)
Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical integration of Clinical and experimental evidence
Souhel Najjar et al.
FRONTIERS IN PSYCHIATRY (2017)
Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders
Suzhen Chen et al.
SCIENTIFIC REPORTS (2017)
Association of serum VEGF levels with prefrontal cortex volume in schizophrenia
A. Pillai et al.
MOLECULAR PSYCHIATRY (2016)
Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study
Sivasankar Devanarayanan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Altered Serum Levels of Matrix Metalloproteinase-2,-9 in Response to Electroconvulsive Therapy for Mood Disorders
Chiyo Shibasaki et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
MMP-9 in translation: from molecule to brain physiology, pathology, and therapy
Behnam Vafadari et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia
Maja Pantovic Stefanovic et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia
Berko Milleit et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia - A Meta-Regression Analysis
Katharine Schuemberg et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers
Wu Hong et al.
SCIENTIFIC REPORTS (2016)
The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis
Benjamin Ian Perry et al.
LANCET PSYCHIATRY (2016)
IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia
Emily G. Severance et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Nerve Growth Factor: A Focus on Neuroscience and Therapy
Luigi Aloe et al.
CURRENT NEUROPHARMACOLOGY (2015)
Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice
Yasuhiro Suzuki et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
S100B blood levels and childhood trauma in adolescent inpatients
Tatiana Falcone et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment
Bun-Hee Lee et al.
PSYCHIATRY RESEARCH (2015)
Metabolic syndrome in drug-naive and drug-free patients with schizophrenia and in their siblings
Asli Enez Darcin et al.
SCHIZOPHRENIA RESEARCH (2015)
Gastroenterology Issues in Schizophrenia: Why the Gut Matters
Emily G. Severance et al.
CURRENT PSYCHIATRY REPORTS (2015)
Premature Mortality Among Adults With Schizophrenia in the United States
Mark Olfson et al.
JAMA PSYCHIATRY (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia
Tomihisa Niitsu et al.
PSYCHIATRY RESEARCH (2014)
Changes in Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor-Beta in Schizophrenic Patients Before and After Treatment
A. Ajami et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
Inflammatory Molecular Signature Associated With Infectious Agents in Psychosis
Lindsay N. Hayes et al.
SCHIZOPHRENIA BULLETIN (2014)
Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis
Brendan P. Murphy et al.
SCHIZOPHRENIA RESEARCH AND TREATMENT (2014)
Nerve growth factor and its receptor in schizophrenia
Roksana Zakharyan et al.
BBA CLINICAL (2014)
Levels of S100B are raised in female patients with schizophrenia
Kara O'Connell et al.
BMC PSYCHIATRY (2013)
Increased plasma agmatine levels in patients with schizophrenia
Tayfun Uzbay et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Intracellular Adhesion Molecule (ICAM-1), Vascular Cell Adhesion Molecule (VCAM-1) and E-Selectin Levels in First Episode Schizophrenic Patients
Semine Ozdogan Kavzoglu et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
The S100B protein in biological fluids: more than a lifelong biomarker of brain distress
Fabrizio Michetti et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Oxidative Stress and Blood-Brain Barrier Dysfunction Under Particular Consideration of Matrix Metalloproteinases
Christine Lehner et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics
Jack Bowden et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Hippocampal interneurons are abnormal in schizophrenia
Christine Konradi et al.
SCHIZOPHRENIA RESEARCH (2011)
Expression of Interneuron Markers in the Dorsolateral Prefrontal Cortex of the Developing Human and in Schizophrenia
Samantha J. Fung et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements
Xiang Yang Zhang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Increased serum S100B in never-medicated and medicated schizophrenic patients
Xiang Yang Zhang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Glial and neuronal control of brain blood flow
David Attwell et al.
NATURE (2010)
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: A PET study with [11C]verapamil as a probe for P-glycoprotein function
Onno L. de Klerk et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2010)
Ultrastructural damage of capillaries in the neocortex in schizophrenia
Natalya A. Uranova et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
A New Pathophysiological Aspect of S100B in Schizophrenia: Potential Regulation of S100B by Its Scavenger Soluble RAGE
Johann Steiner et al.
BIOLOGICAL PSYCHIATRY (2009)
Neuropeptide Y Its multiple effects in the CNS and potential clinical significance
Eduardo E. Benarroch
NEUROLOGY (2009)
Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment
Bun-Hee Lee et al.
NEUROPSYCHOBIOLOGY (2009)
Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics
Ling Yan Qi et al.
NEUROSCIENCE LETTERS (2009)
Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia - Original research and meta-analysis
Matthias L. Schroeter et al.
PSYCHIATRY RESEARCH (2009)
Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia
Janusz K. Rybakowski et al.
SCHIZOPHRENIA RESEARCH (2009)
Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naive psychotic patients
Anvita Kale et al.
SCHIZOPHRENIA RESEARCH (2009)
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry
Jaime L. Peters et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales
Julian P. T. Higgins et al.
STATISTICS IN MEDICINE (2008)
Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment
Ash Sarandol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol
Matthias Rothermundt et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Increased levels of serum soluble L-selectin in unmedicated patients with schizophrenia
Yasuhide Iwata et al.
SCHIZOPHRENIA RESEARCH (2007)
Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment
Si-hai Ling et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones
J. Steiner et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse
Maria C. Jockers-Scheruebl et al.
NEUROSCIENCE LETTERS (2006)
Increased serum S100B in elderly, chronic schizophrenic patients: Negative correlation with deficit symptoms
A Schmitt et al.
SCHIZOPHRENIA RESEARCH (2005)
ICAM G241A polymorphism and soluble ICAM-1 serum levels: Evidence for an active immune process in schizophrenia
H Kronig et al.
NEUROIMMUNOMODULATION (2005)
Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects
G Bersani et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2004)
Cortical GABA interneurons in neurovascular coupling: Relays for subcortical vasoactive pathways
B Cauli et al.
JOURNAL OF NEUROSCIENCE (2004)
S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia
M Rothermundt et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients
MC Jockers-Scherübl et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia
ML Schroeter et al.
SCHIZOPHRENIA RESEARCH (2003)
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo
G Cantarella et al.
FASEB JOURNAL (2002)
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology
M Rothermundt et al.
MOLECULAR PSYCHIATRY (2001)
Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors
L Calzà et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Increased serum S100B protein in schizophrenia: a study in medication-free patients
DR Lara et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2001)
Decreased S100-beta protein in schizophrenia:: preliminary evidence
WF Gattaz et al.
SCHIZOPHRENIA RESEARCH (2000)
分享论文
